Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill August 13, 2026
Photys Therapeutics and Polymed Biopharmaceuticals Announce the Initiation of aPhase I Clinical Trial of PHT-776/HPB-143, an Oral IRAK4PROTAC Degrader August 13, 2026
Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases August 6, 2026
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates August 3, 2026
Evommune Initiates Phase 2b Clinical Trial of MRGPRX2 Inhibitor EVO756 in Migraine Prophylaxis August 3, 2026
TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies July 31, 2026
